Global report - July 10, 2020
Pfizer starts Phase 3 clinical trials for investigational vaccines
Pfizer has announced the initiation of four Phase 3 clinical trials within its current pipeline of investigational vaccines. “The start of four Phase 3 studies across our portfolio of investigational vaccines is a testament to the talented and dedicated colleagues working throughout Pfizer, and the continued commitment to unlock the potential promise and value that […]
COVID-19 - July 6, 2020
Pfizer and BioNTech announces early data from vaccine candidate study
Pfizer and BioNTech has announced preliminary data from the most advanced of four investigational vaccine candidates from their BNT162 mRNA-based vaccine program, Project Lightspeed, against SARS-CoV-2. The BNT162 program is evaluating at least four experimental vaccines, each of which represents a unique combination of mRNA format and target antigen. Overall, the preliminary data demonstrated that […]
COVID-19 - March 17, 2020
Pfizer and BioNTech to co-develop potential COVID-19 vaccine
Pfizer and BioNTech have announced that the companies have agreed to a letter of intent regarding the co-development and distribution (excluding China) of a potential mRNA-based coronavirus vaccine aimed at preventing COVID-19 infection. The companies have executed a Material Transfer and Collaboration Agreement to enable the parties to immediately start working together. “This is a […]
COVID-19 - March 12, 2020
Pfizer has identified antiviral compounds with potential as coronavirus treatment
In the beginning of March Pfizer reported that the company had identified certain antiviral compounds it had in development that have the potential to inhibit coronaviruses and is engaging with a third party to screen the compounds. The company said it hopes to have the results from that screening by the end of March and […]
In a new job - May 20, 2019
She is the new Chair of the Research-based Pharmaceutical Industry in Sweden
Malin Parkler, CEO of Pfizer Sweden, has been appointed new Chair of the Board of the Research-based Pharmaceutical Industry in Sweden (LIF). Parkler was elected to the Board of LIF in 2014 and she was elected Vice Chair of the Board of LIF in 2018. Since February 2019 she has been the Chair of the […]
Global report - September 4, 2017
Pfizer’s patent criticized
The pharma giant was recently granted a patent on their vaccine for pneumonia in India, which has been highly questioned by for example Medecins sans Frontiers (MSF). The patent approval means that other pharma companies are not allowed to manufacture cheaper versions of the vaccine and this is a major backlash in the fight for […]
